Child influenza treatment.

The child influenza pandemic (known as influenza) is an acute respiratory epidemic caused by influenza viruses and is characterized by high levels of transmission and rapid transmission, which pose a serious threat to children ‘ s health. In pediatric clinical work, the treatment of children ‘ s influenza has allowed me to accumulate valuable experience and commitment. Child influenza symptoms are usually more severe and more sudden than common flu. Patients tend to experience high heat, with rapid temperature rises to above 39 °C, accompanied by visible signs of weakness, muscular acidity, headache, coughing and ingesting. Young infants and young children may be characterized by mental infirmity, reduced appetite, rapid breathing, etc. As children ‘ s immune systems are not yet fully developed, their resistance to influenza viruses is relatively weak, and the disease is likely to progress more rapidly, giving rise to serious complications such as pneumonia, heartitis and encephalitis. Clinical symptoms were an important basis for the diagnosis of child influenza, but laboratory testing was also essential. Rapid influenza antigen testing is one of the most common methods, and although its sensitivity may be limited, it has some diagnostic value for children with symptoms typical of early onset. If the antigen test results are negative, but there is a high level of clinical suspicion of influenza, it can also be tested for influenza virus nucleic acid, which is the “gold standard” for the diagnosis of influenza. In addition, routine blood testing helps to determine whether or not a bacterial infection is combined, while mammograms help to detect lung complications. In terms of treatment, the early application of anti-influenza virus drugs is key. The use of Ostawe, which is a clinically commonly used anti-influenza virus, has significantly reduced the pathology, reduced symptoms and reduced the incidence of complications for children with a disease within 48 hours. The use of Ostave may benefit children with severe influenza or with high risk factors for influenza complications, even if the incidence exceeds 48 hours. In the course of the drug use, the dose is to be calculated strictly on the basis of the weight of the affected child to ensure the safety and effectiveness of the drug. In addition to anti-viral treatment, treatment for the disease is equally important. For high-heat patients, deheating treatment should be provided in a timely manner, with the option of acetaminophenol or broven. At the same time, care should be taken to supplement the moisture to prevent dehydration. Coughing has a serious impact on children ‘ s lives and can be used appropriately. Respiratory support such as oxygen is required for children suffering from respiratory difficulties and low oxygen haemorrhage. Changes in the condition of a sick child also need to be closely observed during the treatment. The focus is on body temperature, breathing, mental state, diet, etc. In cases where children continue to suffer from high fever, increased coughing, agitated breathing and infirmity, they should be alert to the occurrence of complications and should be examined and treated in a timely manner. Vaccination is one of the most effective measures for the prevention of influenza among children. It is recommended that children over six months of age be vaccinated against influenza each year before the onset of the flu season. At the same time, the development of personal hygiene practices for children, such as hand-washing, coughing or sneezing with paper towels and avoiding exposure to influenza patients, should be strengthened. There is a need for ventilation and disinfection in densely populated places, such as schools and child-care institutions, to reduce opportunities for transmission of the virus. In communication with parents of affected children, they should be made fully aware of the characteristics and hazards of the flu and should be made more sensitive to the disease. At the same time, parents are given detailed information on the treatment programmes and the main points of care to enable them to cooperate actively with the treatment and to provide home-based care for the ill. Looking back at the experience of children ‘ s influenza, I am acutely aware of the importance of timely and accurate diagnosis, sound and effective treatment and comprehensive care for the recovery of children. As paediatricians, we must not only have solid expertise and clinical experience, but also a high degree of responsibility and patience to focus on the physical and mental health of the sick and to protect their development. In my future work, I will continue to learn and explore to improve the level of care for children ‘ s influenza and to bring health and hope to more children. At the same time, it is hoped that our efforts will enable all sectors of society to pay greater attention to the prevention and control of child influenza and to work together to create a healthy environment for children.